161 related articles for article (PubMed ID: 38512618)
1. Locoregional staging of breast cancer: contrast-enhanced mammography versus breast magnetic resonance imaging.
Terzoni A; Basile P; Gambaro AC; Attanasio S; Rampi AM; Brambilla M; Carriero A
Radiol Med; 2024 Apr; 129(4):558-565. PubMed ID: 38512618
[TBL] [Abstract][Full Text] [Related]
2. Contrast-enhanced mammography (CEM) versus MRI for breast cancer staging: detection of additional malignant lesions not seen on conventional imaging.
Taylor DB; Burrows S; Saunders CM; Parizel PM; Ives A
Eur Radiol Exp; 2023 Feb; 7(1):8. PubMed ID: 36781808
[TBL] [Abstract][Full Text] [Related]
3. The PROCEM study protocol: Added value of preoperative contrast-enhanced mammography in staging of malignant breast lesions - a prospective randomized multicenter study.
Åhsberg K; Gardfjell A; Nimeus E; Ryden L; Zackrisson S
BMC Cancer; 2021 Oct; 21(1):1115. PubMed ID: 34663236
[TBL] [Abstract][Full Text] [Related]
4. Contrast enhanced mammography (CEM) versus magnetic resonance imaging (MRI) for staging of breast cancer: The pro CEM perspective.
Lobbes MBI; Heuts EM; Moossdorff M; van Nijnatten TJA
Eur J Radiol; 2021 Sep; 142():109883. PubMed ID: 34358810
[TBL] [Abstract][Full Text] [Related]
5. The role of contrast-enhanced mammography in the preoperative evaluation of invasive lobular carcinoma of the breast.
Giannotti E; Van Nijnatten TJA; Chen Y; Bicchierai G; Nori J; De Benedetto D; Lalji U; Lee AHS; James J
Clin Radiol; 2024 Jun; 79(6):e799-e806. PubMed ID: 38383254
[TBL] [Abstract][Full Text] [Related]
6. Contrast-Enhanced Mammography (CEM) compared to Breast Magnetic Resonance (MRI) in the evaluation of breast lobular neoplasia.
Nicosia L; Rotili A; Pesapane F; Bozzini AC; Battaglia O; Pellegrino G; Fusco N; Porta FM; Frassoni S; Bagnardi V; Corso G; Sangalli C; Cassano E
Breast Cancer Res Treat; 2024 Jan; 203(1):135-143. PubMed ID: 37787819
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic Performance of MRI, Molecular Breast Imaging, and Contrast-enhanced Mammography in Women with Newly Diagnosed Breast Cancer.
Sumkin JH; Berg WA; Carter GJ; Bandos AI; Chough DM; Ganott MA; Hakim CM; Kelly AE; Zuley ML; Houshmand G; Anello MI; Gur D
Radiology; 2019 Dec; 293(3):531-540. PubMed ID: 31660801
[TBL] [Abstract][Full Text] [Related]
8. Preoperative evaluation of breast cancer: Contrast-enhanced mammography versus contrast-enhanced magnetic resonance imaging: A systematic review and meta-analysis.
Shahraki Z; Ghaffari M; Nakhaie Moghadam M; Parooie F; Salarzaei M
Breast Dis; 2022; 41(1):303-315. PubMed ID: 35754256
[TBL] [Abstract][Full Text] [Related]
9. Patient perspectives on repeated contrast-enhanced mammography and magnetic resonance during neoadjuvant chemotherapy of breast cancer.
Pires-Gonçalves L; Henriques Abreu M; Ferrão A; Guimarães Dos Santos A; Aguiar AT; Gouvêa M; Henrique R
Acta Radiol; 2023 May; 64(5):1816-1822. PubMed ID: 36575580
[TBL] [Abstract][Full Text] [Related]
10. Low-Dose, Contrast-Enhanced Mammography Compared to Contrast-Enhanced Breast MRI: A Feasibility Study.
Clauser P; Baltzer PAT; Kapetas P; Hoernig M; Weber M; Leone F; Bernathova M; Helbich TH
J Magn Reson Imaging; 2020 Aug; 52(2):589-595. PubMed ID: 32061002
[TBL] [Abstract][Full Text] [Related]
11. Contrast-enhanced mammography versus breast MRI in the assessment of multifocal and multicentric breast cancer: a retrospective study.
Hafez MAF; Zeinhom A; Hamed DAA; Ghaly GRM; Tadros SFK
Acta Radiol; 2023 Nov; 64(11):2868-2880. PubMed ID: 37674355
[TBL] [Abstract][Full Text] [Related]
12. Utility of MRI-Directed Contrast-Enhanced Mammography for Biopsy Planning for Suspicious MRI-Detected Breast Lesions.
Nida BA; Rooney TB; Miller MM
AJR Am J Roentgenol; 2023 Feb; 220(2):202-211. PubMed ID: 36000664
[No Abstract] [Full Text] [Related]
13. Dynamic contrast-enhanced mammography and breast MRI in the diagnosis of breast cancer and detection of tumor size.
Tekinhatun M; Sabir N; Erdem E; Yilmaz S; Ufuk F
Turk J Med Sci; 2024; 54(1):249-261. PubMed ID: 38812642
[TBL] [Abstract][Full Text] [Related]
14. Is contrast-enhanced mammography (CEM) an alternative to MRI in assessing the response to primary systemic therapy of breast cancer?
Sunen I; Isabel Garcia Barrado A; Cruz Ciria S; Garcia Maroto J; Gros Bañeres B; Garcia Mur C
Eur J Radiol; 2024 Jan; 170():111270. PubMed ID: 38141263
[TBL] [Abstract][Full Text] [Related]
15. Added value of contrast-enhanced mammography (CEM) in staging of malignant breast lesions-a feasibility study.
Åhsberg K; Gardfjell A; Nimeus E; Rasmussen R; Behmer C; Zackrisson S; Ryden L
World J Surg Oncol; 2020 May; 18(1):100. PubMed ID: 32438917
[TBL] [Abstract][Full Text] [Related]
16. Contrast-enhanced Mammography versus Contrast-enhanced Breast MRI: A Systematic Review and Meta-Analysis.
Pötsch N; Vatteroni G; Clauser P; Helbich TH; Baltzer PAT
Radiology; 2022 Oct; 305(1):94-103. PubMed ID: 36154284
[TBL] [Abstract][Full Text] [Related]
17. Contrast-enhanced mammography in breast cancer screening.
Coffey K; Jochelson MS
Eur J Radiol; 2022 Nov; 156():110513. PubMed ID: 36108478
[TBL] [Abstract][Full Text] [Related]
18. Patient preferences regarding use of contrast-enhanced imaging for breast cancer screening.
Son D; Phillips J; Mehta TS; Mehta R; Brook A; Dialani VM
Acad Radiol; 2022 Jan; 29 Suppl 1():S229-S238. PubMed ID: 33846061
[TBL] [Abstract][Full Text] [Related]
19. The performance of contrast-enhanced mammography and breast MRI in local preoperative staging of invasive lobular breast cancer.
Lobbes MBI; Neeter LMFH; Raat F; Turk K; Wildberger JE; van Nijnatten TJA; Nelemans PJ
Eur J Radiol; 2023 Jul; 164():110881. PubMed ID: 37201248
[TBL] [Abstract][Full Text] [Related]
20. Preoperative staging by multimodal imaging in newly diagnosed breast cancer: Diagnostic performance of contrast-enhanced spectral mammography compared to conventional mammography, ultrasound, and MRI.
Daniaux M; Gruber L; De Zordo T; Geiger-Gritsch S; Amort B; Santner W; Egle D; Baltzer PAT
Eur J Radiol; 2023 Jun; 163():110838. PubMed ID: 37080064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]